Literature DB >> 25546791

Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.

C Geis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546791      PMCID： PMC4285520          DOI： 10.1111/cei.12540

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.

Authors:  Julien Ratelade; Alex J Smith; A S Verkman
Journal:  Exp Neurol       Date:  2014-03-14       Impact factor: 5.330

Review 2.  Neuromyelitis optica: potential roles for intravenous immunoglobulin.

Authors:  Dean M Wingerchuk
Journal:  J Clin Immunol       Date:  2012-09-14       Impact factor: 8.317

3.  Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.

Authors:  Sean J Pittock; Vanda A Lennon; Andrew McKeon; Jay Mandrekar; Brian G Weinshenker; Claudia F Lucchinetti; Orna O'Toole; Dean M Wingerchuk
Journal:  Lancet Neurol       Date:  2013-04-26       Impact factor: 44.182

4.  Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.

Authors:  Christian Geis; Andreas Weishaupt; Stefan Hallermann; Benedikt Grünewald; Carsten Wessig; Thomas Wultsch; Andreas Reif; Nadiya Byts; Marcus Beck; Sibylle Jablonka; Michael K Boettger; Nurcan Üçeyler; Wernher Fouquet; Manfred Gerlach; Hans-Michael Meinck; Anna-Leena Sirén; Stephan J Sigrist; Klaus V Toyka; Manfred Heckmann; Claudia Sommer
Journal:  Brain       Date:  2010-09-30       Impact factor: 13.501

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

6.  Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.

Authors:  Niels Hansen; Benedikt Grünewald; Andreas Weishaupt; Maria Nandini Colaço; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  Exp Neurol       Date:  2012-10-23       Impact factor: 5.330

7.  The effect of intravenous immunoglobulin on neuromyelitis optica.

Authors:  M J Magraner; F Coret; B Casanova
Journal:  Neurologia       Date:  2012-07-28       Impact factor: 3.109

8.  Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG).

Authors:  Jacqueline Bakker; Luanne Metz
Journal:  Can J Neurol Sci       Date:  2004-05       Impact factor: 2.104

9.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

10.  Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.

Authors:  Tatsuro Misu; Romana Höftberger; Kazuo Fujihara; Isabella Wimmer; Yoshiki Takai; Shuhei Nishiyama; Ichiro Nakashima; Hidehiko Konno; Monika Bradl; Ferenc Garzuly; Yasuto Itoyama; Masashi Aoki; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2013-04-12       Impact factor: 17.088
  10 in total
  1 in total

1.  Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.

Authors:  R Marignier; A Ruiz; S Cavagna; A Nicole; C Watrin; M Touret; S Parrot; G Malleret; C Peyron; C Benetollo; N Auvergnon; S Vukusic; P Giraudon
Journal:  J Neuroinflammation       Date:  2016-05-18       Impact factor: 8.322
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.